Encysive Pharmaceuticals (ENCY) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Encysive Pharmaceuticals (ENCY)

An SI Board Since November 2005

Posts	SubjectMarks	Bans
205	11	0

Emcee: tuck	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
30	I am very short but I am still p'd at this management. What kind of mickey	kenhott	-	3/27/2006
29	Jack, Actually you could do much better than just avoiding these events. You s	IRWIN JAMES FRANKEL	-	3/26/2006
28	There is a conference call scheduled for Monday morning before market opening.	Jack@SI	-	3/26/2006
27	UPDATE 2- US FDA seeks more trial work on Encysive lung drug Fri Mar 24, 2006 8:	nigel bates	-	3/25/2006
26	>>UPDATE 1-US FDA says Encysive lung drug "approvable" Fri Mar 2	tuck	-	3/24/2006
25	Encysive Cuts to Chase By Melissa Davis Senior Writer 3/24/2006 1:01 PM EST UR	Doc Bones	-	3/24/2006
24	Thanks, yeah, that's weird that they used it. Couldn't they just throw	tuck	-	3/24/2006
23	ENCY Reuters reported 'The company did not disclose any specific details on	Syncrude	-	3/24/2006
22	UBS says no biggie and Rodman says this could be important. I was hoping to get	Robohogs	-	3/24/2006
21	On the day that we expect a decision on Thelin from the FDA, we get a hold on th	tuck	-	3/24/2006
20	Thanks for taking the time to post those great notes from Cowen Conf. I have gu	LJM	-	3/8/2006
19	Turns out there was a leak, and so ENCY had to disclose the DHF trial. I was ri	tuck	-	3/7/2006
18	ENCY starting trial for Thelin in diastolic heart failure: >>6-Mar-2006	tuck	-	3/6/2006
17	<i><<Is that long enough for a good assessment of impact on LFTs?>	LJM	-	2/13/2006
16	>>HOUSTON, Feb. 13 /PRNewswire-FirstCall/ -- Encysive Pharmaceuticals (Nas	tuck	-	2/13/2006
15	DJ Encysive Pharma CEO: Market Misinterpreted Myogen Data 10 Jan 12:05 NEW Y	LJM	-	1/10/2006
14	Got it, thanks. Here's the start of a trial of TBC3711 -- its very specific	tuck	-	1/9/2006
13	150 patients for pah sounds like it could be a phase III. ardm device is a fol	rkrw	-	1/9/2006
12	UTHR's inhalable Remodulin trial, called a PIII in the protocol: clinicaltr	tuck	-	1/8/2006
11	Praveen, I was talking about similar efficacy to tracleer. Which I thought was v	rkrw	-	12/19/2005
10	ENCY:Hi Jim, I respectfully disagree with you on this Jim:-) Tracleer and Thel	dr.praveen	-	12/19/2005
9	>>I don't think selling will be a problem. Doesn't take a ton of r	tuck	-	12/19/2005
8	I don't think there's any reason to think remodoulin won't work well	rkrw	-	12/19/2005
7	>>Tuck, earlier stage patients will be on combos, no question about it. Bu	tuck	-	12/19/2005
6	Tuck, earlier stage patients will be on combos, no question about it. But I'	rkrw	-	12/19/2005

Go to reply# or date (mm/dd/yy):